Pharma Nordic ApS: Financial statements 2026
CVR: 37842338
Source: annual report 2026, Danish Business Authority
01/10/2025 – 30/09/2026
Pharma Nordic ApS (CVR 37842338) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2026 report amounted to DKK -23,687.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK -23,687
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | -24K | - |
| 2025 | 0 | 0 | 0 | -24K | - |
| 2024 | 0 | -5K | -5K | -24K | - |
| 2023 | 100K | -117K | 55K | -19K | - |
| 2022 | 52K | -108K | -110K | 876K | - |
Official annual report
Find more companies like Pharma Nordic ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout Pharma Nordic ApS
Pharma Nordic ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Anden udlejning af boliger. The management consists of Niels Skovmand Juhl. The company is owned by Niels Skovmand Juhl, Christopher Skovmand Møller Juhl and Stephanie Skovmand Møller Juhl. According to the 2021 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2026 report amounted to DKK -23,687.